Targeted therapies developed to reduce lung fibrosis
Philip S. Low, Purdue’s Ralph C. Corley Distinguished Professor of Chemistry and Presidential Scholar for Drug Discovery, has led a team to develop two targeted therapies for people with idiopathic pulmonary fibrosis (IPF).